Observation Unit Management of Acute Decompensated Heart Failure

Heart Failure Clinics

Volumn 5, Issue 1, 2009, Pages 85-100

  Schrock, Jon W ^a   Emerman, Charles L ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Heart failure; Observation medicine

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUMETANIDE; CAPTOPRIL; CARVEDILOL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; HYDROCHLOROTHIAZIDE; INOTROPIC AGENT; ISOSORBIDE DINITRATE; ISOSORBIDE DINITRATE PLUS HYDROCHLOROTHIAZIDE; LISINOPRIL; LOOP DIURETIC AGENT; LOSARTAN; METOLAZONE; METOPROLOL; NESIRITIDE; NITRIC ACID DERIVATIVE; NITROPRUSSIDE SODIUM; SILDENAFIL; THIAZIDE DIURETIC AGENT; TROPONIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALSARTAN;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; AFRICAN AMERICAN; ANGIONEUROTIC EDEMA; ANOREXIA; ANTICOAGULANT THERAPY; BABY BOOMER; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; BRADYCARDIA; CARDIOLOGY; CLINICAL PROTOCOL; CONTINUOUS INFUSION; COUGHING; CREATININE BLOOD LEVEL; DETERIORATION; DIARRHEA; DIET; DIZZINESS; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; ELECTROCARDIOGRAPHY; EMERGENCY CARE; EXERCISE; FATIGUE; FINANCIAL MANAGEMENT; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERCALCEMIA; HYPERGLYCEMIA; HYPERKALEMIA; HYPERLIPIDEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOTENSION; INCIDENCE; INSTITUTIONAL CARE; KIDNEY FAILURE; LENGTH OF STAY; LIVER FUNCTION TEST; LOADING DRUG DOSE; LUNG EDEMA; MEDICAID; MEDICARE; MUSCLE CRAMP; OBSERVATION UNIT; OLIGURIA; OTOTOXICITY; OUTCOME ASSESSMENT; PATIENT EDUCATION; PATIENT MONITORING; PATIENT SELECTION; PHYSICIAN; PRIMARY MEDICAL CARE; PROGNOSIS; PROTEIN BLOOD LEVEL; REIMBURSEMENT; REVIEW; RHABDOMYOLYSIS; RISK ASSESSMENT; SMOKING CESSATION; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TELEMETRY; THYROID FUNCTION; ULTRAFILTRATION; UREA NITROGEN BLOOD LEVEL; VOMITING;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; EMERGENCY SERVICE, HOSPITAL; HEART FAILURE; HOSPITALIZATION; HUMANS; HYDRALAZINE; INTERNATIONAL CLASSIFICATION OF DISEASES; LENGTH OF STAY; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PATIENT SELECTION; POSITIVE-PRESSURE RESPIRATION; UNITED STATES;

EID: 56149120982     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2008.08.015     Document Type: Review

References (127)

1. Hugli O., Braun J.E., Kim S., et al. United States emergency department visits for acute decompensated heart failure, 1992 to 2001. Am J Cardiol 96 11 (2005) 1537-1542
2. Burt C.W., and Schappert S.M. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999-2000. Vital Health Stat 13 157 (2004) 1-70
3. Massie B.M., and Shah N.B. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 133 6 (1997) 703-712
4. O'Connell J.B., and Bristow M.R. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 13 4 (1994) S107-S112
5. O'Connell J.B. The economic burden of heart failure. Clin Cardiol 23 Suppl.3 (2000) III6-III10
6. Graff L., Orledge J., Radford M.J., et al. Correlation of the agency for health care policy and research congestive heart failure admission guideline with mortality: peer review organization voluntary hospital association initiative to decrease events (provide) for congestive heart failure. Ann Emerg Med 34 4 Pt 1 (1999) 429-437
7. Polanczyk C.A., Rohde L.E., Philbin E.A., et al. A new casemix adjustment index for hospital mortality among patients with congestive heart failure. Med Care 36 10 (1998) 1489-1499
8. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 4 (2008) e25-146
9. Stewart S., MacIntyre K., Capewell S., et al. Heart failure and the aging population: an increasing burden in the 21st century?. Heart 89 1 (2003) 49-53
10. Ansari M., and Massie B.M. Heart failure: how big is the problem? Who are the patients? What does the future hold?. Am Heart J 146 1 (2003) 1-4
11. Storrow A.B., Collins S.P., Lyons M.S., et al. Emergency department observation of heart failure: preliminary analysis of safety and cost. Congest Heart Fail 11 2 (2005) 68-72
12. Peacock W.F., Remer E.E., Aponte J., et al. Effective observation unit treatment of decompensated heart failure. Congest Heart Fail 8 2 (2002) 68-73
13. Ross M.A., Compton S., Medado P., et al. An emergency department diagnostic protocol for patients with transient ischemic attack: a randomized controlled trial. Ann Emerg Med 50 2 (2007) 109-119
14. Trommald M., Aaserud M., and Bjorndal A. [Observational units-same good service to lower costs?]. Tidsskr Nor Laegeforen 120 25 (2000) 3029-3034 [in Norwegian]
15. Goodacre S., Nicholl J., Dixon S., et al. Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care. BMJ 328 7434 (2004) 1-6
16. Roberts R.R., Zalenski R.J., Mensah E.K., et al. Costs of an emergency department-based accelerated diagnostic protocol vs hospitalization in patients with chest pain: a randomized controlled trial. JAMA 278 20 (1997) 1670-1676
17. Gaspoz J.M., Lee T.H., Weinstein M.C., et al. Cost-effectiveness of a new short-stay unit to "rule out" acute myocardial infarction in low risk patients. J Am Coll Cardiol 24 5 (1994) 1249-1259
18. Peacock W., Holland R., Gyarmathy R., et al. Observation unit treatment of heart failure with nesiritide: results from the proaction trial. J Emerg Med 29 3 (2005) 243-252
19. McDermott M.F., Murphy D.G., Zalenski R.J., et al. A comparison between emergency diagnostic and treatment unit and inpatient care in the management of acute asthma. Arch Intern Med 157 18 (1997) 2055-2062
20. Rydman R.J., Zalenski R.J., Roberts R.R., et al. Patient satisfaction with an emergency department chest pain observation unit. Ann Emerg Med 29 1 (1997) 109-115
21. Henneman P.L., Marx J.A., Cantrill S.C., et al. The use of an emergency department observation unit in the management of abdominal trauma. Ann Emerg Med 18 6 (1989) 647-650
22. Shen W.K., Decker W.W., Smars P.A., et al. Syncope evaluation in the emergency department study (seeds): a multidisciplinary approach to syncope management. Circulation 110 24 (2004) 3636-3645
23. Graff L., Radford M.J., and Werne C. Probability of appendicitis before and after observation. Ann Emerg Med 20 5 (1991) 503-507
24. Aghababian R.V. Acutely decompensated heart failure: opportunities to improve care and outcomes in the emergency department. Rev Cardiovasc Med 4 Suppl. 3 (2002) S3-S9
25. Kelen G.D., Scheulen J.J., and Hill P.M. Effect of an emergency department (ed) managed acute care unit on ED overcrowding and emergency medical services diversion. Acad Emerg Med 8 11 (2001) 1095-1100
26. Ross M.A., Wilson A.G., and McPherson M. The impact of an ED observation unit bed on inpatient bed availability. Acad Emerg Med 8 5 (2001) 576
27. Diamond N.J., Schofferman J.A., and Elliot J.W. Evaluation of an emergency department observation ward. JACEP 5 1 (1976) 29-31
28. Landers Fa W.J., and McNbney W.K. Observation ward utilization. JACEP 4 (1975) 123-125
29. Emergency department observation units. American college of emergency physicians. Ann Emerg Med 17 1 (1988) 95-96
30. Centers for Medicare & Medicaid Services. CMS manual system. Department of Health & Human Services. Pub 100-04 Medicare claims processing. Available at:. http://www.cms.hhs.gov/transmittals/downloads/R1430CPTXT.pdf Accessed September 15, 2008
31. Yealy D.M., De Hart D.A., Ellis G., et al. A survey of observation units in the United States. Am J Emerg Med 7 6 (1989) 576-580
32. Department of Health and Human Services. Medicare and Medicaid Programs. Interim and Final Rule. Federal Register. Available at: http://www.cms.hhs.gov/HospitalOutpatientPPS/Downloads/cms1392fc.pdf. Accessed December 13, 2007.
33. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from breathing not properly (BNP) multinational study. Circulation 106 4 (2002) 416-422
34. Clerico A., Fontana M., Zyw L., et al. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the n-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem 53 5 (2007) 813-822
35. Dokainish H., Zoghbi W.A., Lakkis N.M., et al. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol 93 9 (2004) 1130-1135
36. Latour-Perez J., Coves-Orts F.J., Abad-Terrado C., et al. Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review. Eur J Heart Fail. 8 4 (2006) 390-399
37. Mueller T., Gegenhuber A., Poelz W., et al. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91 5 (2005) 606-612
38. Wang C.S., FitzGerald J.M., Schulzer M., et al. Does this dyspneic patient in the emergency department have congestive heart failure?. JAMA 294 15 (2005) 1944-1956
39. Benjamin E.J., Levy D., Vaziri S.M., et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271 11 (1994) 840-844
40. Adams Jr. K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (ADHERE). Am Heart J 149 2 (2005) 209-216
41. VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287 12 (2002) 1531-1540
42. Smith W.R., Poses R.M., McClish D.K., et al. Prognostic judgments and triage decisions for patients with acute congestive heart failure. Chest 121 5 (2002) 1610-1617
43. Butler J., Hanumanthu S., Chomsky D., et al. Frequency of low-risk hospital admissions for heart failure. Am J Cardiol 81 1 (1998) 41-44
44. Diercks D.B., Peacock W.F., Kirk J.D., et al. ED patients with heart failure: identification of an observational unit-appropriate cohort. Am J Emerg Med 24 3 (2006) 319-324
45. Burkhardt J., Peacock W.F., and Emerman C.L. Predictors of emergency department observation unit outcomes. Acad Emerg Med 12 9 (2005) 869-874
46. Auble T.E., Hsieh M., Gardner W., et al. A prediction rule to identify low-risk patients with heart failure. Acad Emerg Med 12 6 (2005) 514-521
47. Fonarow G.C., Adams Jr. K.F., Abraham W.T., et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293 5 (2005) 572-580
48. Lee D.S., Austin P.C., Rouleau J.L., et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290 19 (2003) 2581-2587
49. Brophy J.M., Deslauriers G., and Rouleau J.L. Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol 10 5 (1994) 543-547
50. Brophy J.M., Deslauriers G., Boucher B., et al. The hospital course and short term prognosis of patients presenting to the emergency room with decompensated congestive heart failure. Can J Cardiol 9 3 (1993) 219-224
51. Auble T.E., Hsieh M., McCausland J.B., et al. Comparison of four clinical prediction rules for estimating risk in heart failure. Ann Emerg Med 50 2 (2007) 127-135
52. Chin M.H., and Goldman L. Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med 156 16 (1996) 1814-1820
53. Hsieh M., Auble T.E., and Yealy D.M. Validation of the acute heart failure index. Ann Emerg Med 51 1 (2008) 37-44
54. Gheorghiade M., Rossi J.S., Cotts W., et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial. Arch Intern Med 167 18 (2007) 1998-2005
55. Felker G.M., Adams Jr. K.F., Gattis W.A., et al. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44 5 (2004) 959-966
56. Butler J., Forman D.E., Abraham W.T., et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147 2 (2004) 331-338
57. Kramer B.K., Schweda F., and Riegger G.A. Diuretic treatment and diuretic resistance in heart failure. Am J Med 106 1 (1999) 90-96
58. Neuberg G.W., Miller A.B., O'Connor C.M., et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 144 1 (2002) 31-38
59. Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289 2 (2003) 194-202
60. Smith G.L., Masoudi F.A., Vaccarino V., et al. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 41 9 (2003) 1510-1518
61. Vasan R.S., Larson M.G., Benjamin E.J., et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 7 (1999) 1948-1955
62. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 355 3 (2006) 260-269
63. George T.L., Hiok C.T., and Leonard K. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 90 12 (2002) 1405
64. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American college of chest physicians and the international society for heart and lung transplantation: endorsed by the heart rhythm society. Circulation 112 12 (2005) e154-e235
65. Demir M., Kanadasi M., Akpinar O., et al. Cardiac troponin t as a prognostic marker in patients with heart failure: a 3-year outcome study. Angiology 58 5 (2007) 603-609
66. Parenti N., Bartolacci S., Carle F., et al. Cardiac troponin I as prognostic marker in heart failure patients discharged from emergency department. Intern Emerg Med 3 (2008) 44-47
67. Peacock W.F., Emerman C.E., Doleh M., et al. Retrospective review: the incidence of non-ST segment elevation MI in emergency department patients presenting with decompensated heart failure. Congest Heart Fail 9 6 (2003) 303-308
68. Missov E., Calzolari C., and Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 96 9 (1997) 2953-2958
69. Glauser J., Erickson J., Bhatt D., et al. Elevated serum cardiac markers predict coronary artery disease in patients with a history of heart failure who present with chest pain: insights from the i*tracs registry. Congest Heart Fail 13 3 (2007) 142-148
70. Dormans T.P., van Meyel J.J., Gerlag P.G., et al. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 28 2 (1996) 376-382
71. Pivac N., Rumboldt Z., Sardelic S., et al. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Int J Clin Pharmacol Res 18 3 (1998) 121-128
72. Lahav M., Regev A., Ra'anani P., et al. Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest 102 3 (1992) 725-731
73. Salvador D.R., Rey N.R., Ramos G.C., et al. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 3 (2005) CD003178
74. Packer M., Coats A.J.S., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 22 (2001) 1651-1658
75. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353 9169 (1999) 2001-2007
76. Hjalmarson A., Goldstein S., Fagerberg B., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). JAMA 283 10 (2000) 1295-1302
77. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 353 9146 (1999) 9-13
78. Kao W., and Surjancev B.P. Management of acute heart failure exacerbation. Crit Care Clin 17 2 (2001) 321-335
79. Cleland J.G.F., Bristow M.R., Erdmann E., et al. Beta-blocking agents in heart failure: should they be used and how?. Eur Heart J 17 11 (1996) 1629-1639
80. Gattis W.A., O'Connor C.M., Gallup D.S., et al. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the initiation management predischarge: process for assessment of carvedilol therapy in heart failure (IMPACT-HF) trial. J Am Coll Cardiol 43 9 (2004) 1534-1541
81. Chadda K., Goldstein S., Byington R., et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 73 3 (1986) 503-510
82. Metra M., Torp-Pedersen C., Cleland J.G., et al. Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Eur J Heart Fail 9 9 (2007) 901-909
83. Shamimi-Noori S W.D., Dasgupta A., Adams S., et al. [abstract]. Beta blocker dose adjustment upon hospitalization for acute decompensated heart failure. J Am Coll Cardiol 40 11 Suppl A (2007) 1028-1066
84. Garg R., and Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor trials. JAMA 273 18 (1995) 1450-1456
85. Nony P., Boissel J.P., Girard P., et al. Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure. Eur Heart J 13 8 (1992) 1101-1108
86. Lee V.C., Rhew D.C., Dylan M., et al. Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction. Ann Intern Med 141 9 (2004) 693-704
87. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial. Lancet 362 9386 (2003) 777-781
88. Morris S.A., Hatcher H.F., and Reddy D.K. Digoxin therapy for heart failure: an update. Am Fam Physician 74 4 (2006) 613-618
89. Ahmed A., Rich M.W., Fleg J.L., et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 114 5 (2006) 397-403
90. Rathore S.S., Curtis J.P., Wang Y., et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289 7 (2003) 871-878
91. Adams Jr. K.F., Patterson J.H., Gattis W.A., et al. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis. J Am Coll Cardiol 46 3 (2005) 497-504
92. Loeb H.S., Johnson G., Henrick A., et al. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA cooperative studies group. Circulation 87 Suppl.6 (1993) VI78-VI87
93. Cohn J.N., Johnson G., Ziesche S., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325 5 (1991) 303-310
94. Taylor A.L., Ziesche S., Yancy C., et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 20 (2004) 2049-2057
95. Patrick K., and Noonan L.Z.B. The bioavailability of oral nitroglycerin. J Pharm Sci 75 3 (1986) 241-243
96. Colucci W.S., Elkayam U., Horton D.P., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide study group. N Engl J Med 343 4 (2000) 246-253
97. Silver M.A., Horton D.P., Ghali J.K., et al. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol 39 5 (2002) 798-803
98. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 12 (2005) 1487-1491
99. Sackner-Bernstein J.D., Kowalski M., Fox M., et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 293 15 (2005) 1900-1905
100. Hauptman P.J., Schnitzler M.A., Swindle J., et al. Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure. JAMA 296 15 (2006) 1877-1884
101. Topol E.J. Nesiritide-not verified. N Engl J Med 353 2 (2005) 113-116
102. Teerlink J.R., and Massie B.M. Nesiritide and worsening of renal function: the emperor's new clothes?. Circulation 111 12 (2005) 1459-1461
103. Shlipak M.G., and Massie B.M. The clinical challenge of cardiorenal syndrome. Circulation 110 12 (2004) 1514-1517
104. Witteles R.M., Kao D., Christopherson D., et al. Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction: a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 50 19 (2007) 1835-1840
105. Riter H.G., Redfield M.M., Burnett J.C., et al. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. J Am Coll Cardiol 47 11 (2006) 2334-2335
106. Fonarow G.C., Heywood J.T., Heidenreich P.A., et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 153 6 (2007) 1021
107. Costanzo M.R., Saltzberg M., O'Sullivan J., et al. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 46 11 (2005) 2047-2051
108. Costanzo M.R., Guglin M.E., Saltzberg M.T., et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49 6 (2007) 675-683
109. Kannel W.B., Plehn J.F., and Cupples L.A. Cardiac failure and sudden death in the Framingham study. Am Heart J 115 4 (1988) 869-875
110. Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation 85 Suppl. I (1992) I50-I56
111. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 12 (2002) 877-883
112. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 3 (2005) 225-237
113. AVID Investigators. The antiarrhythmics versus implantable defibrillators I. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 22 (1997) 1576-1584
114. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 25 (1999) 1882-1890
115. Peacock W.F. Using the emergency department clinical decision unit for acute decompensated heart failure. Cardiol Clin 23 4 (2005) 569-588 viii
116. Deborah Diercks P., and Frank W. Short stay management of heart failure (2006), Lippincott Williams & Wilkins, Philadelphia
117. Meldon S, Ma OJ, Woolard R, American college of emergency medicine. Geriatric emergency medicine. 1st edition. New York: McGraw-Hill, Health Professions Division; 2004.
118. Peacock W., Frank A.J.H., Craig Mary T., et al. Predictors of unsuccessful treatment for congestive heart failure in the emergency department observation unit. Acad Emerg Med 4 5 (1997) 493-494
119. Johnson D., Jin Y., Quan H., et al. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol 42 8 (2003) 1438-1445
120. Koelling T.M., Johnson M.L., Cody R.J., et al. Discharge education improves clinical outcomes in patients with chronic heart failure. Circulation 111 2 (2005) 179-185
121. Rich M.W., Beckham V., Wittenberg C., et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333 18 (1995) 1190-1195
122. Krumholz H.M., Amatruda J., Smith G.L., et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 39 1 (2002) 83-89
123. Phillips C.O., Wright S.M., Kern D.E., et al. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA 291 11 (2004) 1358-1367
124. Lightwood J., Fleischmann K.E., and Glantz S.A. Smoking cessation in heart failure: it is never too late. J Am Coll Cardiol 37 6 (2001) 1683-1684
125. Suskin N., Sheth T., Negassa A., et al. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol 37 6 (2001) 1677-1682
126. Lancaster T., Stead L., Silagy C., et al. Effectiveness of interventions to help people stop smoking: findings from the cochrane library. BMJ 321 7257 (2000) 355-358
127. Simpson E., Beck C., Richard H., et al. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J 145 3 (2003) 438-444